Anti-SMAD6 antibody (323-372 aa) (STJ95703)

SKU:
STJ95703
£49.00 - £261.00
Processing The item has been added

Short Description :Rabbit polyclonal anti-Mothers against decapentaplegic homolog 6 (323-372 aa) for use in WB, IHC, IF and ELISA in Human and Mouse samples. Datasheet included with dilution recommendations, and related reagents.
Applications:WB/IHC/IF/ELISA
Host:Rabbit
Reactivity:Human/Mouse
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Polyclonal
Isotype:IgG
Conjugation:Unconjugated
Concentration:1 mg/mL
Purification:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Dilution Range:WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:40000
IF 1:50-200
Formulation:Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Storage Instruction:Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol:SMAD6
Gene ID:4091
Uniprot ID:SMAD6_HUMAN
Immunogen:The antiserum was produced against synthesized peptide derived from the human Smad6 at the amino acid range 323-372
Immunogen Region:323-372 aa
Specificity:Smad6 Polyclonal Antibody detects endogenous levels of Smad6 protein.
Post Translational Modifications Phosphorylated by BMP type 1 receptor kinase and by PRKX. Monoubiquitinated at Lys-173 by the E2/E3 hybrid ubiquitin-protein ligase UBE2O, leading to reduced binding affinity for the activated BMP type I receptor ACVR1/ALK2, thereby enhancing BMP7 and regulating adipocyte differentiation. Ubiquitinated by WWP1. Ubiquitinated by ARK2C, promoting proteasomal degradation, leading to enhance the BMP-Smad signaling. Arginine methylation by PRMT1, which is recruited by BMPR2, initiates BMP-Induced signaling and induces dissociation from the BMPR1B receptor at the cell surface leading to derepress downstream Smad1/Smad5 signaling.
Function Transforming growth factor-beta superfamily receptors signaling occurs through the Smad family of intracellular mediators. SMAD6 is an inhibitory Smad (i-Smad) that negatively regulates signaling downstream of type I transforming growth factor-beta. Acts as a mediator of TGF-beta and BMP anti-inflammatory activities. Suppresses IL1R-TLR signaling through its direct interaction with PEL1, preventing NF-kappa-B activation, nuclear transport and NF-kappa-B-mediated expression of pro-inflammatory genes. Blocks the BMP-SMAD1 signaling pathway by competing with SMAD4 for receptor-activated SMAD1-binding. Binds to regulatory elements in target promoter regions.
Protein Name Mothers Against Decapentaplegic Homolog 6
Mad Homolog 6
Mothers Against Dpp Homolog 6
Smad Family Member 6
Smad 6
Smad6
Hsmad6
Database Links Reactome: R-HSA-201451
Reactome: R-HSA-8941326
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Mothers Against Decapentaplegic Homolog 6 antibody
Anti-Mad Homolog 6 antibody
Anti-Mothers Against Dpp Homolog 6 antibody
Anti-Smad Family Member 6 antibody
Anti-Smad 6 antibody
Anti-Smad6 antibody
Anti-Hsmad6 antibody
Anti-SMAD6 antibody
Anti-MADH6 antibody

Information sourced from Uniprot.org